Meningitis B vaccine rejected

A vaccine that protects against a potentially deadly form of meningitis should not be offered to children in the UK, immunisation experts have said.

View all 4 updates ›

Meningitis B vaccine 'unlikely to be cost-effective'

There is "insufficient" evidence available to support the introduction a Meningitis B immunisation, Government-appointed experts have said.

The Joint Committee on Vaccination and Immunisation (JCVI) said the efficacy of the Bexsero vaccine "has not been established" and it is "high unlikely" to be cost-effective.

The vaccine was licensed by the European Medicines Agency at the start of the year.

More top news